DreamCIS INC. Logo

DreamCIS INC.

A CRO providing clinical research services for pharma, biotech, and medical device industries.

223250 | KO

Overview

Corporate Details

ISIN(s):
KR7223250002
LEI:
Country:
South Korea
Address:
서울특별시 종로구 사직로 130 적선현대빌딩, 10층 10호, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DreamCIS, Inc. is a Contract Research Organization (CRO) that provides comprehensive clinical research services for the pharmaceutical, biotechnology, and medical device industries. The company's offerings include clinical development, biostatistics, data management, project management, and consulting. DreamCIS has extensive experience in managing clinical trials across a broad range of therapeutic areas, including oncology, cardiovascular diseases, endocrinology, and rare diseases. It also conducts Non-Interventional Studies (NIS) and Post-Marketing Surveillance (PMS) to support products throughout their lifecycle.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 99.0 KB
2025-08-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 8.8 KB
2025-08-14 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.5 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-06-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-09 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 15.1 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.0 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.8 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.0 MB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-20 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 445.3 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 18.5 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 215.3 KB

Automate Your Workflow. Get a real-time feed of all DreamCIS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DreamCIS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DreamCIS INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.